# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3854585 | B | Binding affinity to Pseudomonas aeruginosa HemO by intrinsic fluorescence quenching method | Pseudomonas aeruginosa | 25 | single protein format | Scientific Literature | ||
2. | ALA3854595 | B | Inhibition of Pseudomonas aeruginosa HemO mutant expressed in Escherichia coli BL21(DE3) assessed as decrease in biliverdin-9alpha-dependent IFP1.4 fluorescence after 16 hrs by spectrophotometric method | Pseudomonas aeruginosa | 25 | assay format | Scientific Literature | ||
3. | ALA3854597 | F | Antibacterial activity against Pseudomonas aeruginosa PAO1 after 12 hrs | Pseudomonas aeruginosa | 25 | assay format | Scientific Literature | ||
4. | ALA3854598 | F | Antibacterial activity against Pseudomonas aeruginosa JSRI-1 clinical isolate after 12 hrs | Pseudomonas aeruginosa | 25 | assay format | Scientific Literature | ||
5. | ALA3854599 | F | Antibacterial activity against Pseudomonas aeruginosa JSRI-2 clinical isolate after 12 hrs | Pseudomonas aeruginosa | 25 | assay format | Scientific Literature | ||
6. | ALA3854600 | F | Bactericidal activity against Pseudomonas aeruginosa PAO1 after 12 hrs | Pseudomonas aeruginosa | 25 | assay format | Scientific Literature | ||
7. | ALA3854601 | F | Bactericidal activity against Pseudomonas aeruginosa JSRI-1 clinical isolate after 12 hrs | Pseudomonas aeruginosa | 25 | assay format | Scientific Literature | ||
8. | ALA3854602 | F | Bactericidal activity against Pseudomonas aeruginosa JSRI-2 clinical isolate after 12 hrs | Pseudomonas aeruginosa | 25 | assay format | Scientific Literature | ||
9. | ALA4772269 | B | Agonist activity at NPFFR1 (unknown origin) expressed in mouse NIH3T3 cells by receptor selection and amplification technology assay relative to control | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
10. | ALA4772270 | B | Agonist activity at NPFFR2 (unknown origin) expressed in mouse NIH3T3 cells by receptor selection and amplification technology assay relative to control | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
11. | ALA4772272 | B | Agonist activity at NPFFR2 (unknown origin) expressed in mouse NIH3T3 cells by receptor selection and amplification technology assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
12. | ALA4772275 | F | Agonist activity at NPFFR2 (unknown origin) expressed in HEK293T cells harboring EP2 incubated for 15 mins by cAMP assay relative to control | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
13. | ALA4772290 | B | Displacement of [3H]-PrRP-20 from human PrRP receptor expressed in CHO cell membrane by TopCount scintillation counter method | Homo sapiens | 2 | cell membrane format | Scientific Literature | ||
14. | ALA4772291 | B | Displacement of [125I]-Kp-10 from human KISS1R expressed in CHO cell membrane by TopCount scintillation counter method | Homo sapiens | 2 | cell membrane format | Scientific Literature | ||
15. | ALA4772292 | B | Displacement of [125I]-43RFa from human QRFP receptor expressed in CHO cell membrane by TopCount scintillation counter method | Homo sapiens | 2 | cell membrane format | Scientific Literature | ||
16. | ALA5150716 | F | Potentiation of Norfloxacin-induced antibacterial activity against Staphylococcus aureus 1199B overexpressing NorA efflux pump assessed as fold reduction in norfloxacin MIC by microdilution method | Staphylococcus aureus | 3 | organism-based format | Scientific Literature | ||
17. | ALA5150717 | F | Potentiation of ethidium bromide-induced antibacterial activity against Staphylococcus aureus 1199B overexpressing NorA efflux pump assessed as fold reduction in ethidium bromide MIC by microdilution method | Staphylococcus aureus | 3 | organism-based format | Scientific Literature |